Dogwood Therapeutics DWTX Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's pre-tax income?
- Dogwood Therapeutics (DWTX) reported pre-tax income of -$4.99M in Q1 2026.
- How has Dogwood Therapeutics's pre-tax income changed year-over-year?
- Dogwood Therapeutics's pre-tax income increased by 53.6% year-over-year, from -$10.73M to -$4.99M.
- What is the long-term trend for Dogwood Therapeutics's pre-tax income?
- Over 4 years (2021 to 2025), Dogwood Therapeutics's pre-tax income has grown at a 20.8% compound annual growth rate (CAGR), from -$15.96M to -$34.04M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.